Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Equity (2016 - 2025)

Historic Return on Equity for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to 2.7%.

  • Ptc Therapeutics' Return on Equity fell 32300.0% to 2.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.7%, marking a year-over-year decrease of 32300.0%. This contributed to the annual value of 0.65% for FY2024, which is 5700.0% down from last year.
  • Per Ptc Therapeutics' latest filing, its Return on Equity stood at 2.7% for Q3 2025, which was down 32300.0% from 1.87% recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Return on Equity registered a high of 11.71% during Q1 2022, and its lowest value of 9.85% during Q4 2021.
  • Moreover, its 5-year median value for Return on Equity was 0.61% (2024), whereas its average is 0.32%.
  • In the last 5 years, Ptc Therapeutics' Return on Equity skyrocketed by 130100bps in 2022 and then plummeted by -102800bps in 2023.
  • Ptc Therapeutics' Return on Equity (Quarter) stood at 9.85% in 2021, then soared by 120bps to 1.96% in 2022, then tumbled by -51bps to 0.96% in 2023, then plummeted by -39bps to 0.58% in 2024, then crashed by -565bps to 2.7% in 2025.
  • Its Return on Equity stands at 2.7% for Q3 2025, versus 1.87% for Q2 2025 and 0.52% for Q1 2025.